Empagliflozin and linagliptin and High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia)
Result of checking the interaction of Empagliflozin and linagliptin and High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia) for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug interaction with food or lifestyle.
Consumer:There have been reports of dose-related increases in LDL cholesterol with the use of SGLT-2 inhibitors. Cholesterol levels should be monitored before and during treatment and appropriate therapy should be initiated if needed.
There have been reports of dose-related increases in LDL cholesterol with the use of SGLT-2 inhibitors. Cholesterol levels should be monitored before and during treatment and appropriate therapy should be initiated if needed.
Generic Name: empagliflozin / linagliptin
Brand Name: Glyxambi
Synonyms: Empagliflozin and Linagliptin